Journal
Frontiers in Aging Neuroscience
Publication Date
1-1-2022
Volume
14
First Page
883131
Document Type
Open Access Publication
DOI
10.3389/fnagi.2022.883131
Rights and Permissions
Aschenbrenner AJ, Hassenstab J, Wang G, Li Y, Xiong C, McDade E, Clifford DB, Salloway S, Farlow M, Yaari R, Cheng EYJ, Holdridge KC, Mummery CJ, Masters CL, Hsiung G-Y, Surti G, Day GS, Weintraub S, Honig LS, Galvin JE, Ringman JM, Brooks WS, Fox NC, Snyder PJ, Suzuki K, Shimada H, Gräber S and Bateman RJ (2022) Avoid or Embrace? Practice Effects in Alzheimer’s Disease Prevention Trials. Front. Aging Neurosci. 14:883131. doi: 10.3389/fnagi.2022.883131 © 2022 Aschenbrenner, Hassenstab, Wang, Li, Xiong, McDade, Clifford, Salloway, Farlow, Yaari, Cheng, Holdridge, Mummery, Masters, Hsiung, Surti, Day, Weintraub, Honig, Galvin, Ringman, Brooks, Fox, Snyder, Suzuki, Shimada, Gräber and Bateman. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Recommended Citation
Aschenbrenner, Andrew J; Hassenstab, Jason; Wang, Guoqiao; Li, Yan; Xiong, Chengjie; McDade, Eric; Clifford, David B; Bateman, Randall J; and et al., "Avoid or embrace? Practice effects in Alzheimer's disease prevention trials." Frontiers in Aging Neuroscience. 14, 883131 (2022).
https://digitalcommons.wustl.edu/oa_4/706
Additional Links
Supplemental material is available for this article at publisher site.
